Vega
Asaf Vega, Herzliya IL
Patent application number | Description | Published |
---|---|---|
20140215175 | EFFICIENT SUSPEND-RESUME OPERATION IN MEMORY DEVICES - A method includes executing a first memory access operation in a memory. A progress indication, which is indicative of a progress of execution of the first memory access operation, is obtained from the memory. Based on the progress indication, a decision is made whether to suspend the execution of the first memory access operation in order to execute a second memory access operation. | 07-31-2014 |
Christophe Vega, Alixan FR
Patent application number | Description | Published |
---|---|---|
20080308664 | Method For Monitoring a Yarn Transforming Process - At least one yarn is unspooled from at least one bobbin using a spindle cap. The unspooling speed and, in a coordinated manner, other parameters associated with the transformation process, are adjusted according to a quantity representative of the amount of yarn remaining wound on the at least one bobbin, so that the unspooling speed remains below limits imposed by unspooling conditions. | 12-18-2008 |
Edgi Eduardo Vega, Newington AU
Patent application number | Description | Published |
---|---|---|
20090078246 | BARBEQUE GRILL ASSEMBLY - A barbeque grill assembly ( | 03-26-2009 |
Esteban Meléndez Vega, Heredia CR
Patent application number | Description | Published |
---|---|---|
20120296305 | Male Light Incontinence Hygienic Article - A hygienic article for personal wear by a male, the hygienic article includes an elongate, liquid permeable, and at least uni-directionally stretchable fabric sleeve having a first end, and a longitudinally opposite second end. A central passage extends longitudinally between the first and second ends of the sleeve, the first end of the sleeve being open to the central passage to permit a wearer's penis to extend through the open first end into the central passage of the sleeve. The second end of the sleeve is permanently affixed to an absorbent cap, either bonded to an end of the sleeve or contained within a closed end of the sleeve, which absorbent cap controls leakage of liquid at the tip of the user's penis. | 11-22-2012 |
Gabriel Chavez Vega, Sinaloa MX
Patent application number | Description | Published |
---|---|---|
20100126424 | Managed Co-cultures of Organisms Having Prophylactic and Health-Promoting Effects - The invention is directed to novel methods that enhance aquaculture of valuable crops. The invention is exemplified by co-culture of | 05-27-2010 |
Ignacio Vega, Countryside, IL US
Patent application number | Description | Published |
---|---|---|
20160135641 | COOKING ASSEMBLY COMPRISING A FLEXIBLE RING CONFORMABLE TO PREDETERMINEDLY SHAPED TEMPLATES OF A COOKING STATION FOR PROVIDING COOKED FOODS WITH PREDETERMINEDLY DIFFERENT SHAPES, AND THE COOKING STATION EMPLOYING THE COOKING ASSEMBLY - A cooking assembly, and a cooking station employing the cooking assembly, is disclosed. The cooking assembly comprises a flexible ring which is conformable to any one of a plurality of different predeterminedly structured templates, any one of which can be interchangeably utilized upon a food station, in order to provide cooked foods with predeterminedly different shapes or configurations as may be desired. | 05-19-2016 |
Isabel Natalia Vega, Provincia Of Neuquen AR
Patent application number | Description | Published |
---|---|---|
20130317135 | WATER SHUT-OFF SYSTEM FOR PRODUCTION AND/OR INJECTION WELLS - Water Shut-off (WSO) system comprising organic products with relatively low viscosity, which are pumped to into a well in liquid state, and after a certain period of time, reach the desired consistence that may vary from a rigid gel, to produce a complete water flow blockage, up to deformable gels, which produce only a partial blockage effect, reducing significantly the water passage and still allowing the oil passage. | 11-28-2013 |
Jonpaul Vega, Highland, UT US
Patent application number | Description | Published |
---|---|---|
20160116178 | REAL-TIME TEMPERATURE MANAGEMENT - A method for real-time temperature management is described. In one embodiment, the method includes configuring a setting to trigger a thermal sensor to capture a thermal image of an area inside a premises and capturing, via the thermal sensor, a first thermal image of the area of the premises. In some embodiments, upon detecting the trigger, the method includes capturing, via the thermal sensor, a second thermal image of the area of the premises and identifying a thermal exchange in the area of the premises by comparing the first thermal image with the second thermal image. | 04-28-2016 |
20160123617 | TEMPERATURE PREFERENCE LEARNING - A method for relative temperature preference learning is described. In one embodiment, the method includes identifying one or more current settings of a thermostat located at a premises, identifying one or more current indoor and outdoor conditions, calculating a current indoor differential between the current indoor temperature and the current target temperature, calculating a current outdoor differential between the current outdoor temperature and the current target temperature, and learning temperature preferences based on an analysis of the one or more current indoor conditions and the one or more current outdoor conditions. The one or more current settings of the thermostat include at least one of a current target temperature, current runtime settings, and current airflow settings. The one or more current indoor and outdoor conditions include at least one of a current temperature, current humidity, current indoor airflow, current atmospheric pressure, current level of precipitation, and current cloud cover. | 05-05-2016 |
20160138819 | HVAC WORKLOAD AND COST LOGIC - A method for HVAC workload and cost logic is described. In one embodiment, the method includes detecting a thermostat of an HVAC system being set to a target temperature and upon detecting the thermostat being set to the target temperature, detecting a current indoor condition and a current outdoor condition. In some embodiments, the method includes calculating an estimated runtime of an HVAC heating or cooling cycle for the target temperature. The estimated runtime is based on the target temperature, the current indoor and outdoor conditions, and on a result of querying a correlation database. The correlation database includes data points for a plurality of previous HVAC heating and cooling cycles. | 05-19-2016 |
20160140257 | SYSTEMS AND METHODS FOR SMART HOME MAPPING - Methods and systems are described for mapping a living space. An example computer-implemented method for mapping a living space includes receiving information about an exterior perimeter of the living space, receiving information about a plurality of interior boundaries of the living space, receiving information about a location for each of a plurality of barriers of the living space, and generating an electronic map of the living space using the information about the exterior perimeter, the plurality of interior boundaries, and the location of each of the plurality of barriers. | 05-19-2016 |
Jose Luis Vega, Kraainem BE
Patent application number | Description | Published |
---|---|---|
20120017947 | DELIVERY PARTICLE - The present application relates to delivery particles comprising benefit agents, and products comprising such delivery particles, as well as processes for making and using such delivery particles and products comprising such delivery particles. The process of making such particles does not unduly degrade the benefit agent and when such particles are employed in a product, they are stable, yet they release the desired amount of benefit agent when such product is used as intended. | 01-26-2012 |
20150252313 | DELIVERY PARTICLE - The present application relates to delivery particles comprising benefit agents, and products comprising such delivery particles, as well as processes for making and using such delivery particles and products comprising such delivery particles. The process of making such particles does not unduly degrade the benefit agent and when such particles are employed in a product, they are stable, yet they release the desired amount of benefit agent when such product is used as intended. | 09-10-2015 |
Julio Cesar Vega, Buenos Aires AR
Patent application number | Description | Published |
---|---|---|
20110053988 | Low-dose, non-irritating nicotine nasal composition to reduce the desire to smoke - A composition for administration to the nasal mucosa of a subject comprises a solution of nicotine or a pharmaceutically acceptable salt thereof in a pharmaceutically acceptable solvent. The composition has a nicotine concentration less than 1.0 mg/ml. The composition used alone assists in reduction of the desire of a subject to smoke tobacco. It also reduces the nasal symptoms associated with administration of higher concentrations of nicotine to the nasal mucosa. | 03-03-2011 |
20120022114 | Low-dose, non-irritating nicotine nasal composition to reduce the desire to smoke - A composition for administration to the nasal mucosa of a subject comprises a solution of nicotine or a pharmaceutically acceptable salt thereof in a pharmaceutically acceptable solvent. The composition has a nicotine concentration less than 0.08 mg/ml. The composition used alone assists in reduction of the desire of a subject to smoke tobacco. It also reduces the nasal symptoms associated with administration of higher concentrations of nicotine to the nasal mucosa. | 01-26-2012 |
20130104881 | Stabilized Metered Dose Inhaler | 05-02-2013 |
Julio Cesar Vega, San Martin AR
Patent application number | Description | Published |
---|---|---|
20120204871 | Stable, non-corrosive formulations for pressurized metered dose inhalers - Pharmaceutical pressurized metered dosing inhalers (MDIs) are disclosed containing at least one dissolved halide substance, a suspended drug substance and a co-solvent, stabilized chemically and also against metal corrosion by the addition of an acid, an unsaturated suspending agent and water. | 08-16-2012 |
Julio César Vega, San Martin AR
Patent application number | Description | Published |
---|---|---|
20120207685 | Non-ozone depleting medicinal formulations with low greenhouse effect - Pharmaceutical pressurized metered dose inhalers are disclosed having a composition free of CFCs and totally or partially free of HFAs, thus allowing the manufacture of medicinal aerosols without damaging the atmospheric ozone layer and with low or negligible greenhouse effect. | 08-16-2012 |
Manuel Vega, Bahia Blanca AR
Patent application number | Description | Published |
---|---|---|
20090238789 | Modified erythropoietin polypeptides and uses thereof - Modified erythropoietin (EPO) polypeptides and other modified therapeutic polypeptides are provided. The EPO polypeptides and other therapeutic polypeptides are modified to exhibit physical properties and activities that differ from the unmodified EPO polypeptides and other unmodified therapeutic polypeptides, respectively. Nucleic acid molecules encoding these polypeptides also are provided. Also provided are methods of treatment and diagnosis using the polypeptides. | 09-24-2009 |
20120094906 | MODIFIED ERYTHROPOIETIN (EPO) POLYPEPTIDES THAT EXHIBIT INCREASED PROTEASE RESISTANCE AND PHARMACEUTICAL COMPOSITIONS THEREOF - Modified erythropoietin (EPO) polypeptides and other modified therapeutic polypeptides are provided. The EPO polypeptides and other therapeutic polypeptides are modified to exhibit physical properties and activities that differ from the unmodified EPO polypeptides and other unmodified therapeutic polypeptides, respectively. Nucleic acid molecules encoding these polypeptides also are provided. Also provided are methods of treatment and diagnosis using the polypeptides. | 04-19-2012 |
20120264686 | MODIFIED ERYTHROPOIETIN (EPO) POLYPEPTIDES THAT EXHIBIT INCREASED PROTEASE RESISTANCE AND PHARMACEUTICAL COMPOSITIONS THEREOF - Modified erythropoietin (EPO) polypeptides and other modified therapeutic polypeptides are provided. The EPO polypeptides and other therapeutic polypeptides are modified to exhibit physical properties and activities that differ from the unmodified EPO polypeptides and other unmodified therapeutic polypeptides, respectively. Nucleic acid molecules encoding these polypeptides also are provided. Also provided are methods of treatment and diagnosis using the polypeptides. | 10-18-2012 |
Manuel Vega, Vigneux-Sur-Seine FR
Patent application number | Description | Published |
---|---|---|
20080260820 | Oral dosage formulations of protease-resistant polypeptides - Oral dosage formulations of the protease-resistant therapeutic polypeptides are provided. The dosage formulations for administration per dosage per day or per week are higher than the subcutaneous dosage. Included among the oral dosage formulations are tablets and capsules, including enteric-coated forms. Methods for treatment or prevention of diseases or conditions that are treatable or preventable by the administration of such oral dosage formulations of protease-resistant polypeptides are provided. | 10-23-2008 |
20080274081 | Rational evolution of cytokines for higher stability, the cytokines and encoding nucleic acid molecules - Compositions of modified cytokines and uses thereof generated using processes and systems for the high throughput directed evolution of peptides and proteins, particularly cytokines that act in complex biological settings, are provided. Also provided are modified cytokines formulated for oral delivery and uses thereof to treat diseases and conditions mediated by cytokines. | 11-06-2008 |
20090053147 | Rational evolution of cytokines for higher stability, the cytokines and encoding nucleic acid molecules - Compositions of modified cytokines and uses thereof generated using processes and systems for the high throughput directed evolution of peptides and proteins, particularly cytokines that act in complex biological settings, are provided. Also provided are modified cytokines formulated for oral delivery and uses thereof to treat diseases and conditions mediated by cytokines. | 02-26-2009 |
20090123974 | Rational evolution of cytokines for higher stability, the cytokines and encoding nucleic acid molecules - Compositions of modified cytokines and uses thereof generated using processes and systems for the high throughput directed evolution of peptides and proteins, particularly cytokines that act in complex biological settings, are provided. Also provided are modified cytokines formulated for oral delivery and uses thereof to treat diseases and conditions mediated by cytokines. | 05-14-2009 |
20090131318 | Rational evolution of cytokines for higher stability, the cytokines and encoding nucleic acid molecules - Compositions of modified cytokines and uses thereof generated using processes and systems for the high throughput directed evolution of peptides and proteins, particularly cytokines that act in complex biological settings, are provided. Also provided are modified cytokines formulated for oral delivery and uses thereof to treat diseases and conditions mediated by cytokines. | 05-21-2009 |
20110130331 | Modified growth hormones - Provided are modified growth hormone polypeptides, nucleic acid molecules encoding modified growth hormone polypeptides and methods of generating modified growth hormone polypeptides. Also provided are methods of treatment using modified growth hormone polypeptides. | 06-02-2011 |
20110142801 | PROTEASE RESISTANT MODIFIED INTERFERON-BETA POLYPEPTIDES AND THEIR USE IN TREATING DISEASES - Protease resistant modified interferon-beta polypeptides, pharmaceutical compositions and methods of treatment by administering the compositions are provided. The modified interferon-beta polypeptides are orally available; hence pharmaceutical compositions formulated for oral administration also are provided. | 06-16-2011 |
20130243855 | Modified coagulation factor IX polypeptides and use thereof for treatment - Provided are modified factor IX (FIX) polypeptides and methods of generating modified FIX polypeptides. Also provided are pharmaceutical compositions, including compositions formulation for oral administration, that contain the modified FIX polypeptides, and methods of treatment using modified FIX polypeptides. | 09-19-2013 |
Manuel Vega, Evry FR
Patent application number | Description | Published |
---|---|---|
20130130263 | GAMETES SEPARATION METHODS, COMPOSITIONS AND USES THEREOF - The present invention relates to a method of separating gametes of a subject, which method comprises discriminating a first population of gametes containing an abnormal nucleic acid sequence involved in a genetic disease or in a multifactorial disorder in the offspring of the subject, from a second population of gametes which does not contain said abnormal nucleic acid sequence. The invention further relates to products and compositions which may be used in such a method. | 05-23-2013 |
Sergio Vega, Ciudad Juarez MX
Patent application number | Description | Published |
---|---|---|
20160090762 | CINCHING STRIKER WITH ADJUSTMENT MECHANISM - An adjustable cinching striker assembly for installation on a vehicle. The adjustable striker assembly includes a mounting frame for selectively mounting the adjustable striker assembly to the vehicle, and a striker moveably coupled to the mounting frame. A motor is coupled to the striker for moving the striker with respect to the mounting frame from an uncinched position to a cinched position, movement of the striker defining a cinching direction. The cinched position is adjustable with respect to the mounting frame. | 03-31-2016 |
Tony Vega, Los Gatos, CA US
Patent application number | Description | Published |
---|---|---|
20150295801 | Distributed Network Delay and Jitter Monitoring Using Fixed and Mobile Network Devices - Inclusion of a simple time-transfer module in client devices and judicious deployment of time-servers in the network enable a network management system to observe, record, and predict network issues. In a wireless network every mobile device can be a probe and monitoring of all parts of the network on a continuous basis can be achieved. | 10-15-2015 |
Vinsensius B. Vega, Singapore SG
Patent application number | Description | Published |
---|---|---|
20100292933 | Methods, systems, and compositions for classification, prognosis, and diagnosis of cancers - The present invention provides methods, systems and compositions for predicting disease susceptibility in a patient. In some embodiments, methods for the classification, prognosis, and diagnosis of cancers are provided. In other embodiments, the present invention provides statistical methods for building a gene-expression-based classifier that may be employed for predicting disease susceptibility in a patient, for classifying carcinomas, and for the prognosis of clinical outcomes. | 11-18-2010 |